BNTC · Benitec Biopharma Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-29 | BUCHI J KEVIN |
Director |
Gift↓
Filing footnotes — Common Stock (Direct)
The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code. |
Common Stock
|
51,813 |
| 2026-05-26 | Friedman David Matthew |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as a Managing Director of Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds"), is holding such options for the benefit of the Funds, and as such Mr. Friedman disclaims beneficial ownership of such options. The Funds, and Suvretta Capital, the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Friedman's board service. The Options will vest in full on the earlier of immediately prior to the Issuer's next annual meeting of stockholders and May 26, 2027. |
Options (right to buy)
|
35,000 |
| 2026-05-22 | Friedman David Matthew |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-01-22 | Mates Sharon |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026. |
Options (right to buy)
|
31,500 |
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
65,800 |
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
11,587 |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
2,516 |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
14,320 |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
7,400 |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
42,600 |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
2,892 |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
16,650 |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
13,950 |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
2,434 |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
1,515 |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
8,700 |
| 2025-12-01 | Mehta Kishan |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options. The Funds, and Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service. The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026. |
Options (right to buy)
|
35,000 |
| 2025-12-01 | Francis Peter |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026. |
Options (right to buy)
|
35,000 |
| 2025-12-01 | BUCHI J KEVIN |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026. |
Options (right to buy)
|
35,000 |
| 2025-12-01 | Smith Edward F |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026. |
Options (right to buy)
|
35,000 |
| 2025-12-01 | Mates Sharon |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026. |
Options (right to buy)
|
3,500 |
| 2025-11-18 | Mukadam Sophie |
Chief Operating Officer |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026. |
Options (right to buy)
|
500,000 |
| 2025-11-18 | Boston Megan |
Director, Chief Financial Officer |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026. |
Options (right to buy)
|
200,000 |
| 2025-11-18 | Banks Jerel A. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026. |
Options (right to buy)
|
450,000 |
| 2025-11-07 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
730,370 |
| 2025-11-07 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
751,111 |
| 2025-11-05 | Mates Sharon |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026. |
Options (right to buy)
|
28,517 |
| 2025-11-03 | Mates Sharon |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
5,057 |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
670 |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
9,503 |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
1,267 |
| 2025-03-26 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
106,200 |
| 2025-03-26 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
793,800 |
| 2025-03-12 | BUCHI J KEVIN |
Director |
Gift↑
Filing footnotes — Common Stock (Indirect)
On March 12, 2025, the reporting person gifted 103,626 shares of Common Stock to a trust for no consideration. The reporting person is trustee of the trust and the reporting person's son is the sole beneficiary. |
Common Stock
(I)
|
103,626 |
| 2025-03-12 | BUCHI J KEVIN |
Director |
Gift↓
|
Common Stock
|
103,626 |
| 2025-02-27 | BUCHI J KEVIN |
Director |
Convert↓
|
Common Warrants (right to buy)
|
51,813 |
| 2025-02-27 | BUCHI J KEVIN |
Director |
Convert↑
|
Common Stock
|
51,813 |
| 2024-12-24 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
2,288 |
| 2024-12-24 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
17,730 |
| 2024-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
3,142 |
| 2024-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
24,360 |
| 2024-12-09 | BUCHI J KEVIN |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025. |
Options (right to buy)
|
35,000 |
| 2024-12-09 | Smith Edward F |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025. |
Options (right to buy)
|
35,000 |
| 2024-12-09 | Francis Peter |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025. |
Options (right to buy)
|
35,000 |
| 2024-12-09 | Banks Jerel A. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025. |
Options (right to buy)
|
2,310,000 |
| 2024-12-09 | Boston Megan |
Director, Chief Financial Officer |
Award↑
Filing footnotes — Options (right to buy) (Direct)
The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025. |
Options (right to buy)
|
720,000 |
| 2024-12-09 | Mehta Kishan |
Director |
Award↑
Filing footnotes — Options (right to buy) (Direct)
Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Mehta in connection with his role as a member of the Issuer's Board of Directors. Mr. Mehta, as Portfolio Manager for Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds") is holding such options for the benefit of the Funds, and as such Mr. Mehta disclaims beneficial ownership of such options. The Funds, and Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of the Funds, may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Mehta's board service. The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025. |
Options (right to buy)
|
35,000 |
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
37,190 |
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC |
Director, 10% Owner |
Buy↑
Filing footnotes — Common stock, par value $0.0001 per share (Indirect)
Notes are included on Exhibit 99.1. Notes are included on Exhibit 99.1. |
Common stock, par value $0.0001 per share
(I)
|
4,810 |